Home

Shuraba Compressed Strength kappa agonist Since Jolly Accessible

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands:  Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel  Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience

Opioid Receptor | kappa, mu Opioid Receptor
Opioid Receptor | kappa, mu Opioid Receptor

Structure–activity relationship investigation of triazole-based kappa  opioid receptor agonists | SpringerLink
Structure–activity relationship investigation of triazole-based kappa opioid receptor agonists | SpringerLink

New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists

BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)

Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse |  National Institute on Drug Abuse (NIDA)
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)

Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist,  Enhances the Diuretic Response and Limits Electrolyte Losses to  Standard-of-Care Diuretics | Hypertension
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension

A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New  Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse |  Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage

Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal  of Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience

A unique natural selective kappa-opioid receptor agonist, salvinorin A, and  its roles in human therapeutics - ScienceDirect
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect

Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist  Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical  Neuroscience
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience

Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid  Agonists
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding  by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics

Nanobody-enabled monitoring of kappa opioid receptor states | Nature  Communications
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications

EX-99.2
EX-99.2

Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist  Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical  Neuroscience
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Opioids: classification, uses, action and dependence - MedicalVerge
Opioids: classification, uses, action and dependence - MedicalVerge

Table II from Systemic kappa opioid receptor agonists in the treatment of  chronic pruritus: a literature review. | Semantic Scholar
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar

Opioid Receptors Mnemonic | Epomedicine
Opioid Receptors Mnemonic | Epomedicine

Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes  for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry

The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology  of Schizophrenia: A Review of the Evidence
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence

Frontiers | A Review of the Therapeutic Potential of Recently Developed G  Protein-Biased Kappa Agonists
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists